Results 101 to 110 of about 1,935,200 (187)

Drug-eluting versus bare-metal stents in large coronary arteries

, 2010
Recent data have suggested that patients with coronary disease in large arteries are at increased risk for late cardiac events after percutaneous intervention with first-generation drug-eluting stents, as compared with bare-metal stents.
Ingrid Ricard, Burkhard Hornig, Alber, Hannes, Pfisterer, Matthias, Brunner-La Rocca, Hans-Peter; id_orcid, Kaiser, Christoph A., Christoph Kaiser, De Servi, Stefano, Rickli, Hans, Hans-Peter Brunner-La Rocca, Galatius, Soeren, Piero Bonetti, Kaiser, Christoph, Hans Rickli, Brunner-La Rocca, Hans-Peter, Pfisterer, Matthias Emil, Paul Erne, Bertel, Osmund, Hornig, Burkhard, Bonetti, Piero, Soeren Galatius, Basket Prove Study Group,, Pedrazzini, Giovanni, Hannes Alber, Franz Eberli, Ricard, Ingrid, Erne, Paul, Matthias Pfisterer, Giovanni Pedrazzini, Osmund Bertel, Stefano De Servi, Eberli, Franz   +31 more
core   +1 more source

Results of endovascular treatment of multivessel coronary artery disease in patients with the different stent types

RUDN Journal of Medicine, 2012
Long-term results of endovascular treatment of multivessel coronary artery disease by using different revascularization strategies were analyzed in 171 patients. Duration of follow up ranged from 12 to 18 months.
Ye R Khairutdinov, Z Kh Shugushev, D A Maximkin, A G Faibushevich, V Yu Baranovich, Yu V Tarichko   +5 more
doaj  

Retained Drug-eluting Stents and Recalcitrant Chronic Rhinosinusitis: A Case Report

Allergy & Rhinology, 2013
Corticosteroids are the mainstay of treatment for refractory chronic rhinosinusitis. The off-label use of steroid-eluting stents has increasingly gained popularity in functional endoscopic sinus surgery for decreasing postoperative inflammation and ...
Phayvanh P. Sjogren Ph.D., Noah P. Parker M.D., Holly C. Boyer M.D.   +2 more
doaj   +1 more source

Comment on “Impact of Chronic Kidney Disease Severity on Clinical Outcomes After Drug‐Eluting Stent Implantation: A Propensity Score–Matched Analysis”

Clinical Cardiology, Volume 49, Issue 11, November 2026.
Mahendra Singh, Sung Soo. Han
wiley   +1 more source

From Caging to Uncaging With Bioadaptors: A Novel Paradigm in Coronary Revascularization

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
The evolution of percutaneous coronary intervention has improved the outcomes of patients with coronary artery disease, but conventional drug‐eluting stents remain limited by late adverse events, reduced vessel compliance, and the inability to restore ...
Placido Maria Mazzone, Marco Spagnolo, Simone Finocchiaro, Maria Sara Mauro, Giacinto Di Leo, Davide Capodanno   +5 more
doaj   +1 more source

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)

, 2008
Imad Sheiban1, Gianluca Villata1, Mario Bollati1, Dario Sillano1, Marzia Lotrionte2, Giuseppe Biondi-Zoccai11Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy; 2Institute of Cardiology, Catholic University, Rome ...
Gianluca Villata, Mario Bollati, Giuseppe Biondi-Zoccai, Imad Sheiban, Marzia Lotrionte, Dario Sillano   +5 more
core  

Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.

, 2007
AIMS: To compare the efficacy and safety of drug-eluting stents vs. bare-metal stents in patients with acute ST-segment elevation myocardial infarction.
Kastrati, A;Dibra, A;Spaulding, C;Laarman, GJ;Menichelli, M;Valgimigli, M;Di Lorenzo, E;Kaiser, C;Tierala, I;Mehilli, J;Seyfarth, M;Varenne, O;Dirksen, MT;Percoco, G;Varricchio, A;Pittl, U;Syvänne, M;Suttorp, MJ;Violini, R;Schömig, A
core   +1 more source

Promoting endothelial recovery and reducing neointimal hyperplasia using sequential-like release of acetylsalicylic acid and paclitaxel-loaded biodegradable stents

International Journal of Nanomedicine, 2014
Cheng-Hung Lee,1,2 Chia-Ying Yu,2 Shang-Hung Chang,1 Kuo-Chun Hung,1 Shih-Jung Liu,2 Chao-Jan Wang,3 Ming-Yi Hsu,3 I-Chang Hsieh,1 Wei-Jan Chen,1 Yu-Shien Ko,1 Ming-Shien Wen1 1Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial
Lee CH, Yu CY, Chang SH, Hung KC, Liu SJ, Wang CJ, Hsu MY, Hsieh IC, Chen WJ, Ko YS, Wen MS   +10 more
doaj  

Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program

Vascular Health and Risk Management, 2009
R Michael Kirchner, J Dawn AbbottDepartment of Cardiology, Rhode Island Hospital, Brown Medical School, Providence, RI, USAAbstract: Drug-eluting stents (DES) have had a major impact in interventional cardiology.
R Michael Kirchner, J Dawn Abbott
doaj  

Coronary stent implantation links to the occurrence of eosinophilia and interstitial pneumonia: a case report and systematic review

BMC Pulmonary Medicine
Background Rapamycin has been extensively utilized for coating coronary artery stents to reduce the occurrence of restenosis, yet there has been limited research on the potential harms of rapamycin-eluting stents. Herein, We report a case of eosinophilia
Fuyun Zhang, Wei Wang, Yingwei Zhu, Yimin Mao, Tongsheng Wang, Pengfei Gao   +5 more
doaj   +1 more source